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Abstract
Background: A number of published randomized controlled trials have been conducted to evaluate visual performance of
blue light-filtering intraocular lenses (IOL) and UV light-filtering intraocular lenses (IOL) after cataract phacoemulsification
surgery. However, results have not always been consistent. Therefore, we carried out a meta-analysis to compare the
effectiveness of blue light-filtering IOLs versus UV light-filtering IOLs in cataract surgery.
Methods and Findings: Comprehensive searches of PubMed, Embase, Cochrane Library and the Chinese BioMedical
literature databases were performed using web-based search engines. Fifteen trials (1690 eyes) were included for systematic
review, and 11 of 15 studies were included in this meta-analysis. The results showed that there were no significant
differences in postoperative mean best corrected visual acuity, contrast sensitivity, overall color vision, or in the blue light
spectrum under photopic light conditions between blue light-filtering IOLs and UV light-filtering IOLs [WMD=20.01, 95%CI
(20.03, 0.01), P=0.46; WMD=0.07, 95%CI (20.04, 0.19), P=0.20; SMD=0.14, 95%CI (20.33, 0.60), P=0.566; SMD=0.20,
95%CI (20.04, 0.43), P=0.099]. However, color vision with blue light-filtering IOLs was significantly reduced in the blue light
spectrum under mesopic light conditions [SMD=0.74, 95%CI (0.29, 1.18), P=0.001].
Conclusion: This meta-analysis demonstrates that postoperative visual performance with blue light-filtering IOLs is
approximately equal to that of UV light-filtering IOLs after cataract surgery, but color vision with blue light-filtering IOLs
demonstrated some compromise in the blue light spectrum under mesopic light conditions.
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Introduction
Globally, cataract is one of the most serious blinding diseases
[1]. Modern cataract surgery is routinely combined with the
implantation of an intraocular lens (IOL). UV light-filtering lenses
have been the dominant IOLs used in modern cataract surgery
since the mid-1980 s because of the growing evidence that
ultraviolet light caused photic retinopathy and cystoid macular
edema [2]. Recently there has been support for increasing the
absorption spectrum of IOLs. The rationale is that UV light-
filtering IOLs do not protect the retina from phototoxic damage
by high-energy, short-wavelength blue light (approximately 400–
480 nm) which is thought to contribute to the pathogenesis of age-
related macular degeneration (AMD) [3,4]. The healthy human
crystalline lens gradually becomes yellow as part of the normal
ageing process. This yellowing reduces the transmission of blue
light, thereby blocking an amount of blue light from reaching the
retina [5]. After cataract extraction, the possibility of retinal
exposure to blue light may accelerate AMD [6]. To address this
potential damage, several blue light-filtering IOLs have been
introduced in recent years. Their yellow tint more closely
replicates the spectral transmission properties of the aged human
crystalline lens than do the UV light-filtering IOLs [7].
Despite the benefits of blue light filtering, concerns were raised
that this could negatively affect visual performance after cataract
surgery [8]. Specifically, controversy remains as to ultimate best
corrected visual acuity (BCVA), contrast sensitivity, color vision and
glare. In recent years, several studies were performed to test visual
function with blue light-filtering IOLs. Some described a better [9–
11] and others, a worse [8,12,13], outcomes. However, we find that
the majority of the literature did not describe any statistically
significant differences in comparisons with UV light-filtering IOLs
[14–17], or, if present, these differences were most likely small.
In this paper, we conduct a systematic review and meta-analysis
of published randomized controlled trials to assess the visual
performance of blue light-filtering IOLs and UV light-filtering
IOLs after cataract surgery.
Materials and Methods
1. Search strategy
Two independent investigators (Zhu and Yu) searched publica-
tions from 2000 to June 30th, 2011 in PubMed, Embase, Cochrane
Library, and the Chinese BioMedical Literature (CBM) databases
by using the combination of MeSH terms ‘‘cataract extraction’’ or
‘‘phacoemulsification’’or ‘‘lens’’or ‘‘intraocular’’or ‘‘implantation’’
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‘‘SN60AT’’ or ‘‘yellow intraocular lens’’ or ‘‘YA60BB’’. In addition,
the reference lists of potentially relevant manuscripts were scanned
backwards to obtain extra eligible studies. No language restrictions
were applied.
2. Inclusion criteria
2.1. Type of study: For inclusion, studies had to be
randomized controlled trials (RCTs) comparing postoperative
visual performance of blue light-filtering IOLs and UV light-
filtering IOLs. Simulation experiments with blue light-filtering
IOLs and UV light-filtering IOLs and clinical trials containing
aspherical or multifocal IOLs were excluded.
2.2. Object of study: Patients with age-related cataract had
phacoemulsification and IOL implantation. Otherwise, patients
with ocular disease, such as glaucoma or age-related macular
degeneration, preexisting systemic disease such as diabetes, or
history of intraocular surgery that could affect the postoperative
visual outcome were excluded.
2.3. Interventions: In addition to the different types of
intraocular lens (blue light-filtering IOL or UV light-filtering IOL)
implanted in the two groups, the interventions were the same.
2.4. Outcome measures: Main outcome measures included
postoperative best corrected visual acuity, contrast sensitivity and
color vision. Secondary outcome measures included postoperative
visual quality assessment and adverse visual events.
3. Data extraction
Two independent investigators (Zhu and Yu) were involved in
data extraction. The third investigator (Zou) examined the results,
and a consensus was reached. The outcome in patients at the end
of follow-up after phacoemulsification and IOL implantation was
reviewed. We extracted the following data from the eligible
studies: (1) general characteristics (title, first author, journal and
year of publication); (2) methodology (type of study, country of
origin, sequence generation, allocation concealment, masking or
blinding, incomplete outcome data, selective reporting and other
sources of bias); (3) subjects (recruitment site, enrollment periods,
inclusion criteria, exclusion criteria, general patient characteris-
tics); (4) Interventions and control groups (model of IOLs); (5)
outcomes (measurement, follow-up time and loss of follow-up); (6)
analysis (statistical methods); (7) results (quantitative results,
qualitative results, postoperative visual quality assessment and
adverse visual events). If original data were unavailable in articles,
a request for original data was sent to the corresponding author.
4. Assessment of methodology quality
Two independent investigators (Zhu and Yu) evaluated the
quality of each study using the Jadad scale [18]. The third
investigator (Zou) examined the results, and a consensus was
reached. The Jadad score is obtained from a possible 5-point scale,
high scores indicating high quality, by yes/no answers to two
questions for randomization and masking, and one question
evaluating the reporting of patient withdrawals and dropouts. One
point is given for each of the following: if the study is described as
randomized, if the study is described as double-blind and if there is
a description of withdrawals or dropouts. Two additional points
are given if the method of randomization and the method of
double blinding are appropriately described.
5. Statistical analysis
The meta-analysis was performed with the Stata version 11.0
(Stata Corp). For continuous data, the weighted mean difference
(WMD) and 95%CI were recommended when all trials used the
same scale to report their outcomes, while standardized mean
difference (SMD) and 95%CI were more appropriate when trials
used different scales to report their outcomes, or the means of their
outcomes differed greatly. For dichotomous data, rate ratio or
relative risk (RR) was strongly recommended for effect statistics for
meta-analysis of randomized trials.
Statistical heterogeneity was tested by Q-test (x
2) [19] for each
outcome, with a significance set at a P value,0.10. Insignificance
indicates that the results of the different trials were similar (P$0.1,
I
2#50%). We evaluated the pooled summary effect by using a
fixed-effect model to reduce the effects of heterogeneity between
trials. Otherwise, data were combined using the random-effect
model (P,0.1, I
2.50%). If I
2.75%, subgroup analysis was used
to analysis the sources of heterogeneity. Sensitivity analysis
calculated within subgroups of studies decided a priori were
performed to assess the robustness of the main conclusions and
explain heterogeneity. To determine whether the results of the
meta-analysis were unduly influenced by any outcome measures in
any one study, we recomputed the meta-analysis statistic after
deleting each outcome measure one at a time.
Individual and pooled results were illustrated by point estimates
and 95% confidence intervals (CIs). Results where the 95% CI did
not include zero (for mean difference) or one (for odds ratio) were
considered statistically significant. Where data could not be
combined, we conducted a descriptive analysis.
Results
1. Literature search
A total of 107 abstracts from the multiple databases were
retrieved, 68 of which were based on their titles and abstracts.
Only 15 randomized controlled trials (RCTs) [14,17,20–32]
recruiting 1690 eyes were included in our analysis. The trials
selection process is shown in Figure 1.
Figure 1. Process of study selection of RCTs.
doi:10.1371/journal.pone.0033013.g001
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Characteristics of RCTs included in the current meta-analysis
are presented in Table 1 and Table 2. More than half of the
studies [20,21,17,23,24,26,28,29,31] (60%, 9/15) were performed
in Europe followed by 4 studies [14,22,30,32] in Asia; one study
[25] from Australia and one study [27] from Brazil. The mean age
of patients in most of the studies ranged from 50 to 88 years. The
mean percentage of female patients ranged from 48.51% to 75%,
as shown in Table 1. The mean follow-up time ranged from 2
months to 2 years (Table 2).
3. Quality assessment
3.1. Sequence generation: In 6 of all the RCTs included in
the systematic review, the investigators described a random
component in the sequence generation process such as: referring
to a random number table [14] or using a computer random
number generator [30] or shuffling envelopes [25,26,31]. The
remainder did not describe the specific methods of random
sequence generation.
3.2. Masking: Of 13 studies that described their masking or
binding, 1 used triple-blinding [30], 8 used double-blinding
[14,20,22–24,26,31,32] and 4 used single-blinding [17,21,25,29].
3.3. Withdrawals: All studies described the data of missing
patients. Among these, 8 studies had missing cases: 6 of 80 (7.5%)
[14]; 86 of 297 (28.96%) [17]; 3 of 31 (9.68%) [23]; 8 of 47
(17.02%) [24]; 10 of 80 (12.5%) [27]; 6 of 50 (12%) [28]; 7 of 80
(8.75%) [30]; and 4 of 80(5%) [31].
3.4. Other sources of bias: Only 2 studies used the
following or an equivalent method to achieve allocation conceal-
ment: sealed envelopes [26] or sequential numbering [14].
Eight studies [14,17,20–22,24,25,32] described the patients’
subjective satisfaction of visual quality between the blue light-
filtering IOL and UV light-filtering IOL after surgery, and the
other studies did not. Therefore, we do not know the existence of
other potential factors.
The quality assessment of included studies is shown in Table 3.
4. Efficacy analysis
4.1. Postoperative best corrected visual acuity (BCVA):
All studies described postoperative BCVA; the results of 8 studies
[23,24,26–30,32] (596 eyes) were LogMAR transformation,
including mean (m), standard deviation (SD) and sample size (n).
Also, these studies had heterogeneity of effect size (P=0.0001,
I
2=78.3%), so the random effect model was used for meta-
analysis. The results are shown in Figure 2. No significant
difference between the two groups [WMD=20.01, 95%CI
(20.03, 0.01), P=0.46], indicated that blue light-filtering IOL
groups and UV light-filtering IOL groups were not significantly
different in postoperative BCVA.
Subgroup analysis was conducted at the same time, according to
the different IOL types. The studies were divided into four
subgroups: blue light-filtering AcrySof Natural SN60AT IOL vs.
UV light-filtering Sensar AR40e IOL (Subgroup 1) [27–29]; blue
light-filtering Hoya YA60BB vs. UV light-filtering VA60BB
(Subgroup 2) [23,24]; blue light-filtering AcrySof Natural
SN60AT IOL vs. UV light-filtering AcrySof SA60AT IOL
(Subgroup 3) [26,30]; and blue light-filtering Hoya YA60BB vs.
UV light-filtering MC61131 (Subgroup 4) [32]. The results are
shown in Figure 3.
All four subgroups were used to produce the random effect
model for BCVA, and the results obtained from any subgroup
show no significant differences. The results are as follows:
Subgroup 1 (SN60AT vs. AR40e IOL, three studies [27–29],
recruiting 258 eyes) [WMD=0.00, 95%CI (20.01, 0.02),
P=0.763]; Subgroup 2 (YA60BB vs. VA60BB, two studies
[23,24], recruiting 134 eyes) [WMD=20.01, 95%CI (20.04,
0.01), P=0.294]; Subgroup 3 (SN60AT vs. SA60AT, two studies
[26,30], recruiting 125 eyes) [WMD=20.02, 95%CI (20.06,
0.02), P=0.27]; Subgroup 4 (YA60BB vs. MC611, one study [32],
recruiting 79 eyes) [WMD=0.01, 95%CI (20.01, 0.03), P=0.42].
All the results indicated that blue light-filtering IOL groups and
Table 1. Characteristics of RCTS (n=15) included in the meta-analysis.
First author (date) Site No. patients No. eyes Age (years)
Sex(%) male:
female Intervention
(test group/control group)
Hayashi 2006 [14] Japan 80 160 71.166.7/70.766.2 12:26/12:24 YA-60BB/VA-60BB
Wirtitsch 2009 [20] Austria 24 48 7468 6:18 YA-60BB/VA-60BB
Barisic ´ 2007 [21] Croatia 60 120 6864.5/6764.2 9:21/9:21 Acrysof Natural IOL/AcrySof MA60BM IOL
Marshall 2005 [17] England 297 594 $60 (0.3/1.0) 29.3:70.7/39.5:60.5 SN60AT/SA60AT
Bhattacharjee 2006 [22] India 13 26 62.1566.68 6:7/6:7 SN60AT/SA60AT
Schmidinger 2008 [23] Austria 31 62 73.4067.64 NA YA-60BB/VA-60BB
Mester 2008 [24] Germany 47 94 Range 50–80 NA YA-60BB/VA-60BB
Leibovitch 2006 [25] Australia 19 19 7466/7466 3:6/6:4 SN60AT/SA60AT
Vuori 2006 [26] Finland 37 52 7268/7367 NA SN60AT/SA60AT
Rocha 2007 [27] Brazil 40 80 71.0/69.2 2:3 SN60AT/Sensar AR40
Caporossi 2009 [28] Italy 50 100 70.264.1/68.465.1 NA SN60AT/Sensar AR40
Caporossi 2007 [29] Italy 50 100 70.264.1/68.465.1 NA SN60AT/Sensar AR40
Pandita 2007 [30] India 80 80 6162.7/5963 51:49/52:48 SN60AT/SA60AT
Neumaier-Ammerer 2010 [31] Austria 80 80 NA NA YA-60BB/VA-60BB & SN60AT/SA60AT
Wang 2010 [32] China 79 79 6768 NA YA-60BB/MC611
NA, not available.
doi:10.1371/journal.pone.0033013.t001
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postoperative BCVA.
4.2. Postoperative contrast sensitivity: Twelve studies
[14,17,20,22–25,28–32] compared the contrast sensitivity of blue
light-filtering IOLs and UV light-filtering IOLs after implantation.
The methods of assessing contrast sensitivity were described in
Table 2. However, most of the literature using several different
methods reported only the contrast sensitivity graph or P value,
but no detailed data. On the other hand, for part of the data in
reports, means and standard deviations cannot be calculated, and
there was failure to pool analysis. Although we tried to contact the
author, results of the corresponding data were not obtained. Thus,
these could cause measurement bias. Thereafter, we conducted a
descriptive analysis with results shown in Table 4.
Only two studies [22,25] recruiting 45 eyes used the same
measurement method (Pelli-Robson contrast sensitivity chart), and
Table 2. Characteristics of RCTS (n=15) included in the meta-analysis.
First author (date) Measurement Follow-up Loss
Visual acuity Contrast sensitivity Color Vision
Hayashi 2006 [14] * * CAT-2000 NA 3 m 6 of 80 (7.5%)
Wirtitsch 2009 [20] * * Holladay * Lanthony D-15 90610 d No
Barisic ´ 2007 [21] * NA NA 6 m No
Marshall 2005 [17] * * CSV-1000E * FM??? D-15 1 y 86 of 297 (28.96%)
Bhattacharjee 2006 [22] * * Pelli-Robson * FM 100-hue 18 m No
Schmidinger 2008 [23] * * Moorfields NA 12 w 3 of 31 (9.68%)
Mester 2008 [24] * * ETDRS???+FACT??? * FM 100-hue 12 m 8 of 47 (17.02%)
Leibovitch 2006 [25] * * Pelli-Robson * FM D-15 6 m No
Vuori 2006 [26] * NA * FM 100-hue 6 m No
Rocha 2007 [27] * NA NA 90 d 10 of 80 (12.5%)
Caporossi 2009 [28] * * Optec 6500 NA 2 y 6 of 50 (12%)
Caporossi 2007 [29] * * Optec 6500 NA 2 m No
Pandita 2007 [30] * * CSV-1000E NA 3 m 7 of 80 (8.75%)
Neumaier-Ammerer 2010 [31] * * CSV-1000E + Pelli-Robson * Roth 28-hue 2 m 4 of 80 (5%)
Wang 2010 [32] * * ETDRS + Optec 6500 * FM 100-hue 3 m No
*, yes; d=days; m=months; y=years; NA, not available.
ETDRS, Early Treatment Diabetic Retinopathy Study contrast charts;
FACT, Functional acuity contrast test;
FM, Farnsworth-Munsell.
doi:10.1371/journal.pone.0033013.t002
Table 3. Evaluation of the quality of RCTs included in the meta-analysis.
Study Sequence generation Double-blind Withdrawals Jadad score(0–5)
Hayashi 2006 [14] Adequate Adequate DS 5
Wirtitsch 2009 [20] Adequate Adequate DS 5
Barisic ´ 2007 [21] UA SB DS 2
Marshall 2005 [17] UA SB DS 2
Bhattacharjee 2006 [22] UA Adequate DS 4
Schmidinger 2008 [23] UA Adequate DS 4
Mester 2008 [24] UA Adequate DS 4
Leibovitch 2006 [25] Adequate SB DS 3
Vuori 2006 [26] Adequate Adequate DS 5
Rocha 2007 [27] UA NA DS 2
Caporossi 2009 [28] UA NA DS 2
Caporossi 2007 [29] UA SB DS 2
Pandita 2007 [30] Adequate Adequate DS 5
Neumaier-Ammerer 2010 [31] Adequate NA DS 4
Wang 2010 [32] UA Adequate DS 4
UA, Unclear; SB, Single blinding; DB, Double blinding; TB, Triple blinding; DS, Described; NA, not available.
doi:10.1371/journal.pone.0033013.t003
Comparison of Two Types of IOLs: A Meta-Analysis
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33013Figure 2. Meta-analysis of postoperative best corrected visual acuity (BCVA).
doi:10.1371/journal.pone.0033013.g002
Figure 3. Subgroup analysis of postoperative best corrected distance visual acuity (BCVA).
doi:10.1371/journal.pone.0033013.g003
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(P=0.609, I
2=0%), so the fixed effect model was used for meta-
analysis. No significant difference between the two groups was
seen [WMD=0.07, 95%CI (20.04, 0.19), P=0.20], indicating
that blue light-filtering IOL groups and UV light-filtering IOL
groups were not significantly different in postoperative contrast
sensitivity. The results are shown in Figure 4.
4.3. Postoperative color vision: Eight studies [17,20,22,24–
26,31,32] compared the color vision of blue light-filtering IOLs
and UV light-filtering IOLs after implantation. The methods of
assessing color vision were described in Table 2. Five of them [24–
26,31,32] reported complete data, and one [24] reported that
color vision for blue with the blue light-filtering IOL was
significantly reduced under photopic and mesopic conditions;
another study [32] reported that the UV light-filtering IOL had
significantly better color vision than the blue light-filtering IOL
under mesopic conditions. The remaining studies showed no
statistically significant difference.
Two studies [25,26] recruiting 71 eyes used different scales to
report their outcomes in overall color vision, so that standard-
ized mean differences (SMD) were more appropriate. They also
had no heterogeneity of effect size (P=0.59, I
2=0%), so the
fixed effect model was used for meta-analysis. No significant
difference between the two groups was seen [SMD=0.14,
95%CI (20.33, 0.60), P=0.566], indicating that blue light-
filtering IOL groups and UV light-filtering IOL groups were not
significantly different in postoperative color vision. The results
are shown in Figure 5.
Table 4. Comparison of postoperative contrast sensitivity in two groups.
Photopic Conditions Mesopic Conditions
Model of IOLs Study With Glare Without Glare With Glare Without Glare
SN60AT/SA60AT Marshall 2005 [17] NA * NA *
Pandita 2007 [30] NA * * *
Neumaier-Ammerer 2010 [31] * * * *
SN60AT/Sensar AR40 Caporossi 2009 [28] NA * NA *
Caporossi 2009 [29] NA * NA *
Hayashi 2006 [14] * * * *
Wirtitsch 2009 [20] The blue light-filtering IOLs had worse contrast sensitibity compared with the UV-filtering IOL.
YA-60BB/VA-60BB Schmidinger 2008 [23] NA * NA NA
Mester 2008 [24] NA * * *
Neumaier-Ammerer 2010 [31] * * * *
YA-60BB/MC611 Wang 2010 [32] * * * *
*, No statistically significant difference; NA, not available.
doi:10.1371/journal.pone.0033013.t004
Figure 4. Meta-analysis of postoperative contrast sensitivity.
doi:10.1371/journal.pone.0033013.g004
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ative color vision in the blue light spectrum under photopic light
conditions. They used different scales to report their outcomes, so
standardized mean differences (SMD) were more appropriate.
Also, they had no heterogeneity of effect size (P=0.806, I
2=0%),
so the fixed effect model was used for meta-analysis. No significant
differences were seen between the two groups [SMD=0.20,
95%CI (20.04, 0.43), P=0.099], indicating that blue light-
filtering IOL groups and UV light-filtering IOL groups were not
significantly different in postoperative color vision in the blue light
spectrum under photopic light conditions. The results are shown
in Figure 6.
In addition, a sensitivity analysis suggested that the result was
stable after deleting anyone’s particular outcome. The results are
shown in Figure 7.
Three studies [24,31,32] recruiting 229 eyes tested postoperative
color vision in the blue light spectrum under mesopic light
conditions. They used different scales to report their outcomes, so
standardized mean differences (SMD) were more appropriate. Also,
they had no heterogeneity of effect size (P=0.05, I
2=61.7%), so the
Figure 5. Meta-analysis of postoperative overall color vision.
doi:10.1371/journal.pone.0033013.g005
Figure 6. Meta-analysis of postoperative color vision in the blue light spectrum under photopic light condition.
doi:10.1371/journal.pone.0033013.g006
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significant difference between the two groups [SMD=0.74, 95%CI
(0.29, 1.18), P=0.001], indicating that color vision for blue with
blue light-filtering IOLs was significantly reduced under mesopic
conditions. The results are shown in Figure 8.
Additionally, the sensitivity analysis revealed that color vision
with blue light-filtering IOLs was significantly reduced under
mesopic conditions in the blue light spectrum. The results are
shown in Figure 9.
4.4. Postoperative subjective satisfaction of visual
quality and adverse visual events: Four studies
[14,20,21,23] reported that different patients’ subjective satisfac-
tion of visual quality between the blue light-filtering IOL and UV
light-filtering IOL after surgery. In the two studies [14,20] that
Figure 7. Sensitivity analysis of postoperative color vision in the blue light spectrum under photopic light condition.
doi:10.1371/journal.pone.0033013.g007
Figure 8. Meta-analysis of postoperative color vision in the blue light spectrum under mesopic light condition.
doi:10.1371/journal.pone.0033013.g008
Comparison of Two Types of IOLs: A Meta-Analysis
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33013used questionnaires for evaluation, Wirtitsch and associates [20]
using a questionnaire regarding color vision or contrast vision or
vision under poor light conditions, they reported that 3 of 24
patients noticed a difference and all could correctly identify the eye
implanted with the blue light-filtering IOL. However, all 3 patients
said that they were not disturbed in binocular vision. In the report
by Hayashi and associates [14], where patients were given a
standardized questionnaire regarding glare symptoms and cya-
nopsia, the authors found that the incidence of patients who
noticed cyanopsia was significantly less in the blue light-filtering
IOL group than in the UV light-filtering IOL group at 2 weeks
after surgery (p=0.0234), but no patients reported cyanopsia at 3
months. In addition, another two studies [21,23] reported different
patients’ subjective satisfaction and subjective color vision in the
left eye and right eye. Barisic ´ and associates [21] described high
satisfaction in patients who were implanted with a blue light-
filtering IOL. Schmidinger and associates [23] found that 2
patients independently reported subjective changes in color vision
in the eye with the blue light-filtering IOL; the changes probably
resulted from the difference in color brightness because yellow
IOLs reduce color brightness in the blue range of visible light.
Furthermore, four studies [17,24,25,32] found no significant
differences in subjective satisfaction of visual quality or lens-
related adverse events in either group after surgery, which only
Wang and associates [32] used the standardized questionnaire
regarding subjective evaluation of glare, halo, and color vision
perception. The remaining studies reported no relevant results in
this regard.
Discussion
This systematic review compared the postoperative visual
performance of RCTs between blue light-filtering IOLs and UV
light-filtering IOLs, with the results showing that no statistically
significant differences were found in comparing postoperative best
corrected visual acuity, contrast sensitivity, and overall color
vision. However, blue light-filtering IOLs demonstrated some
compromise in the blue light spectrum under mesopic light
conditions.
Large-scale epidemiological and animal studies have demon-
strated that exposure to short wavelength visible light may be
associated with a potential risk for accelerating the pathology of
age-related macular degeneration (AMD) and retinal damage
[2,3,33–35]. The natural aging crystalline lens can absorb
amounts of UV and visible light, due to natural yellowing and
opacification, going against the phototoxicity-AMD hypothesis
[5]. Evidence suggests that blue light can damage the macula in
patients who have undergone cataract surgery or clear lens
extraction [6]. Therefore, an ideal IOL should be similar to that of
the adult crystalline lens. Blue light-filtering IOLs show transmit-
tance curves similar to that of a 53-year-old person’s natural
crystalline lens to help reduce the potential damage from blue light
reaching the retina [7].
The implantation of blue light-filtering IOLs caused debate over
their potential negative effects on postoperative visual perfor-
mance, such as BCVA, contrast sensitivity and color vision,
especially in dark conditions. We found that most of the literature
overwhelmingly demonstrated that there were no detrimental
effects of blue light-filtering IOLs on clinical visual recovery, which
was consistent with our results. However, Mester and associates
[24], in one of the included studies, mentioned that color vision in
the blue light spectrum with the blue light-filtering IOLs (HOYA
YA60BB) was significantly reduced under mesopic and photopic
conditions: the impairment did not exceed the normal range or
induce subjective disturbance of color vision. Furthermore, Barisic ´
and associates [21] indicated that the blue light-filtering IOLs
(HOYA YA60BB) had inferior contrast acuity and foveal threshold
compared with the UV light-filtering IOLs. Unfortunately, we
could not obtain complete data for a pooled analysis. Wang and
associates [32] reported that blue light-filtering IOLs gave poor
contrast sensitivity and color vision under mesopic conditions,
which was in agreement with the conclusions of Neumaier-
Ammerer and associates [31]. In fact, blue light-filtering IOLs
Figure 9. Sensitivity analysis of postoperative color vision in the blue light spectrum under mesopic light condition.
doi:10.1371/journal.pone.0033013.g009
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cyanopsia in the early postoperative period [11,36].
Meta-analysis is the pooling of data from a number of different
studies and objectively reanalyzing the resulting data set to provide
a more precise result to assist in making clinical decisions. A
possible limitation includes inappropriate pooling of data and
publication bias. In our analysis, to avoid acknowledged and
unintended duplication of data, we included only the most recent
series of patient groups and randomized controlled trials, which
are the optimal choice for meta-analyses. To minimize the
publication bias, we conducted an electronic search and a manual
search of the references of relevant studies to identify all the
potential articles. This systematic review included 15 studies, all of
which met the strict inclusion criteria; therefore, the intervention
groups and control groups were comparable. However, the overall
quality of the studies was not high. Only six studies had adequate
sequence generation, two studies used adequate methods to
achieve allocation concealment, and 2 studies made no mention of
masking. In addition, different follow-up times and less reporting
of postoperative visual adverse events could cause selection bias.
Several studies lacked sufficient data for analysis, or involved
different measurement methods, or used different units of
measurement, or not used a standard questionnaire to assess: all
of these could cause measurement bias. All the information in this
systematic review came from the published literature, with special
reports or unpublished data not being included, as they could
cause publication bias. Therefore, to improve the quality of RCTs
in the future, further verification of the postoperative visual
performance and safety of blue light-filtering IOLs is needed. The
format of reports should comply with the rules of CONSORT,
providing detailed and transparent information in order to judge
the authenticity of the outcomes.
In conclusion, our systematic review, as well as other clinical
reports, suggests that the blue light-filtering IOLs had postoper-
ative visual performance comparable to the UV light-filtering
IOLs, but conclusions regarding color vision are still inconsistent.
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